3-descladinose-2,3-anhydroerythromycin derivatives
US5750510A · kind A · utility
17Cited by
0References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 1997 |
| Grant date | May 12, 1998 |
| Priority date | — |
| Expiry date | Apr 4, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 3-descladinose-2,3-anhydroerythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.